rss
J Epidemiol Community Health 63:293-298 doi:10.1136/jech.2008.080861
  • Research report

The mental health impact of AIDS-related mortality in South Africa: a national study

  1. L Myer1,2,
  2. S Seedat3,
  3. D J Stein3,4,
  4. H Moomal5,
  5. D R Williams6
  1. 1
    School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
  2. 2
    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
  3. 3
    MRC Stress and Anxiety Disorders Unit, Department of Psychiatry, University of Stellenbosch, Tygerberg, South Africa
  4. 4
    Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa
  5. 5
    University of the Witwatersrand, Johannesburg, South Africa
  6. 6
    Department of Society, Human Development and Health, Harvard School of Public Health, Boston, USA
  1. Professor L Myer, School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory 7925, Cape Town, South Africa; landon.myer{at}uct.ac.za
  • Accepted 21 November 2008
  • Published Online First 15 December 2008

Abstract

Background: Few data exist on how the HIV/AIDS epidemic may influence population mental health. The associations were examined between knowing someone who died of HIV/AIDS and common mental disorders among South African adults.

Methods: Between 2002 and 2004, a nationally representative sample of 4351 adults were interviewed about personally knowing someone who died of HIV/AIDS, and the World Health Organization Composite International Diagnostic Interview was used to generate psychiatric diagnoses for depression, anxiety and substance abuse disorders during the preceding 12 months based on the Diagnostic and Statistical Manual, 4th edition (DSM-IV).

Results: Overall, 42.2% of the sample knew someone who died of HIV/AIDS, and 16.5% met the criteria for at least one DSM-IV diagnosis. Individuals who knew someone who died of HIV/AIDS were significantly more likely to have any DSM-IV defined disorder, including any depressive, anxiety or substance-related disorder (p<0.001 for all associations). In multivariate models adjusted for participant demographic characteristics, life events and socioeconomic status, individual disorders significantly associated with knowing someone who died of HIV/AIDS included generalised anxiety disorder, social phobia and alcohol/drug dependence or abuse. Based on these results, it is estimated that up to 15% of 12-month DSM-IV disorders in the South African adult population may be related to knowing someone who died of HIV/AIDS.

Conclusion: These novel data suggest that AIDS-related mortality may contribute substantially to the burden of mental disorders in settings of high HIV prevalence. While this finding requires further investigation, these data suggest the need to strengthen mental health services in communities where HIV/AIDS is prevalent.

Footnotes

  • Competing interests: None declared.

  • Funding: Supported by the United States National Institute of Mental Health (R01MH070884), the John D and Catherine T MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864 and R01 DA016558), the Fogarty International Center (FIRCA R01-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline and Bristol-Myers Squibb. The South Africa Stress and Health study was funded by grant R01-MH059575 from the National Institute of Mental Health and the National Institute of Drug Abuse with supplemental funding from the South African Department of Health and the University of Michigan. D Stein and S Seedat are also supported by the Medical Research Council of South Africa.

  • Ethics approval: The survey protocol, including all recruitment, consent and field procedures, was approved by the Human Subjects Committees of the University of Michigan, Harvard Medical School, and by a single project assurance of compliance from the Medical University of South Africa that was approved by the National Institute of Mental Health (USA).